NM_001127222.2(CACNA1A):c.4988G>A (p.Arg1663Gln) AND Episodic ataxia type 2
- Germline classification:
- no classifications from unflagged records (1 submission)
- Last evaluated:
- Mar 23, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000679889.10
Allele description [Variation Report for NM_001127222.2(CACNA1A):c.4988G>A (p.Arg1663Gln)]
NM_001127222.2(CACNA1A):c.4988G>A (p.Arg1663Gln)
Condition(s)
- Name:
- Episodic ataxia type 2 (EA2)
- Synonyms:
- Episodic ataxia with nystagmus; Nystagmus-associated episodic ataxia; Cerebellopathy, hereditary paroxysmal; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0007163; MedGen: C1720416; Orphanet: 97; OMIM: 108500
Assertion and evidence details
Flagged submissions
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV000807290 | Baylor Genetics | flagged submission Reason: Outlier claim with insufficient supporting evidence Notes: None (ACMG Guidelines, 2015) | Uncertain significance (Sep 1, 2017) | de novo | clinical testing |
Last Updated: Nov 10, 2024